文献速递肾小球疾病

尿液白细胞表面分子CD11b与狼疮肾炎肾小球炎症相关

Urinary levels of the leukocyte surface molecule CD11b associate with glomerular inflammation in lupus nephritis.
PubMed 文献 · Kidney Int · 2019-01-31

本研究纳入272例经活检证实的肾小球疾病患者(含118例狼疮肾炎),检测尿CD11b和CD16b水平。尿CD11b与狼疮肾炎肾小球白细胞数量及总体组织病理活动度相关,且成功糖皮质激素治疗后下降,预测增殖性狼疮肾炎优于CD16b、CD163和MCP-1。

要点

  • 尿CD11b与狼疮肾炎肾小球白细胞浸润及病理活动度相关。
  • 尿CD11b预测增殖性狼疮肾炎优于CD16b、CD163和MCP-1。
  • 糖皮质激素治疗后尿CD11b水平下降,或可用于监测疗效。

核心结论

  • 尿CD11b可能是有用的生物标志物,用于评估狼疮肾炎组织病理活动度,尤其是肾小球白细胞积聚。

研究设计与样本

  • 研究纳入272例经活检证实的肾小球疾病患者,包括118例狼疮肾炎,采用ELISA检测尿CD11b和CD16b。

主要发现

  • 狼疮肾炎患者尿CD11b和CD16b均升高,但仅尿CD11b与肾小球白细胞数量和总体组织病理活动度相关。
  • 在部分有活检时和临床缓解后样本的狼疮肾炎患者中,尿CD11b水平随成功的糖皮质激素治疗下降。
  • ROC曲线分析显示尿CD11b预测增殖性狼疮肾炎优于CD16b、CD163和MCP-1。
  • 在抗小鼠肾毒血清肾小球肾炎模型中,尿CD11b与组织学损伤相关,并随糖皮质激素治疗下降。

临床怎么用

  • 尿CD11b或可作为无创标志物辅助评估狼疮肾炎肾小球炎症活动度,并监测糖皮质激素治疗反应。

局限性

  • 部分分析基于子集患者,需进一步验证;机制研究主要来自动物模型和体外实验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Noninvasive biomarkers of disease activity are needed to monitor response to therapy and predict disease recurrence in patients with glomerulonephritis. The leukocyte surface markers integrin Mac-1 and CD16b have been implicated in the pathogenesis of lupus nephritis (LN). Mac-1 comprises a unique α subunit (CD11b) complexed with a common β2 subunit, which are released along with CD16b from specific leukocyte subsets under inflammatory conditions including glomerulonephritis. We investigated the association of urinary CD11b and CD16b with histopathological activity in 272 patients with biopsy-proven glomerular diseases, including 118 with LN. Urine CD11b and CD16b were measured via enzyme-linked immunosorbent assay. Urinary levels of both markers were increased in LN, but only urinary CD11b was correlated with the number of glomerular leukocytes and with overall histopathological activity. In a subset of patients with samples available from the time of biopsy and subsequent clinical remission of LN, urinary levels of CD11b decreased with successful glucocorticoid treatment. Receiver-operating characteristic curve analysis demonstrated that urinary CD11b was superior to CD16b, the scavenger receptor CD163, and monocyte chemotactic protein-1 for the prediction of proliferative LN. In anti-mouse nephrotoxic serum glomerulonephritis, urinary CD11b correlated with histologic damage and decreased with corticosteroid treatment. In vitro, CD11b levels were decreased on activated mouse neutrophils displaying Fcγ receptor clustering and transendothelial migration, suggesting that leukocyte activation and transmigration are required for CD11b shedding in urine. Together, our results suggest that urinary CD11b may be a useful biomarker to estimate histopathological activity, particularly glomerular leukocyte accumulation, in LN.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Kitagawa A, Tsuboi N, Yokoe Y, et al. Urinary levels of the leukocyte surface molecule CD11b associate with glomerular inflammation in lupus nephritis. Kidney Int. 2019. PMID: 30712924. doi:10.1016/j.kint.2018.10.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。